Filing Details
- Accession Number:
- 0001567619-19-012278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-28 20:18:56
- Reporting Period:
- 2019-05-23
- Accepted Time:
- 2019-05-28 20:18:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1685720 | C Kathryn Zoon | 400 Professional Drive Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-23 | 5,736 | $0.00 | 24,379 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-05-28 | 1,376 | $43.39 | 23,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.
- These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.
- The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.04 to $43.58, inclusive.
Billionaire Hedge Funds
